nivolumab,tegafur,oxaliplatin,oteracil,gimeracil,capecitabine
ono pharma,nordic group,otsuka,bms
['nivo', 'gastric', 'nivolumab', 'attraction-5']
attraction-5 study showing adjuvant nivolumab + chemo didn't improve rfs vs. adjuvant chemo in resectable gastric cancer.
maybe positive signal in pd-l1+ and stage iiic pts? overall a negative study. #asco23 
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own